• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • grants, donations, and sponsorships
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update

Nov 7, 2024

Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024

Oct 24, 2024

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

Sep 6, 2024

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

Sep 3, 2024

Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024

Axogen, Inc. Reports Second Quarter 2024 Financial Results

Aug 8, 2024

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Jul 23, 2024

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

Jul 1, 2024

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Jun 24, 2024

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

May 28, 2024
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...34
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms and Conditions
    • Website Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2025 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.